Loading Events

« All Events

  • This event has passed.

ISSX MDO Annual Meeting

September 11, 2022 - September 15, 2022

Join us at ISSX/MDO 2022: the 24th International Symposium on Microsomes and Drug Oxidations (MDO) and 13th International Meeting of the International Society for the Study of Xenobiotics (ISSX). This meeting will convene at the Westin Seattle, September 11-14, 2022 and the meeting theme is Diversity in DMPK – the Science and the Scientists.

This is the second co-organized meeting for MDO and ISSX and it provides an extremely valuable and truly unique opportunity for researchers to gather and exchange ideas and expertise. In addition to an outstanding scientific program, the meeting provides you with access to state-of-the-art exhibits and ample opportunities to present your work during our poster presentation sessions.

Come and meet with the Discovery ADMET and Preclinical Services team at ISSX 2022 at Booth #19!
To schedule a meeting, email gentestsupport@dls.com

Poster Sessions 
P95 – Tuesday 9/13 12:30-1:30pm
Cytotoxcic Reactive Metabolite Assay with Permeabilized Cryopreserved Human Hepatocytes for the Identification of Drug Candidates with Potential to Cause Idiosyncratic Drug-Induced Liver Injuries

P68 – Tuesday 9/13 1:30-2:30pm
Entetic Versus Hepatic Uridine 5′-Diphospho (UDP)-Glucu­ronosyltransferase (UDT) Activity: A Compatison of Cryopreserved Human Intestinal Mucosa (CHIM) and Cryopreserved Human Hepatocytes (CHH) in the Enzyme Kinetics of B-Estradiol, Chenodeoxycholic Acid.

 

Sponsoring Social Event
Join us for a wonderful evening at the Seattle Art Museum!
Tuesday Sept. 13th, 6:00-8:00pm
Welcome address from Gentest leadership, food and beverages will be served, and the exhibits will be open. 

 

Don’t Miss Dr. Albert Li’s Presentation
Tuesday Sep 13th, 2:00-3:00pm at the St. Helen’s Meeting Room | Westin Seattle, 2nd FloorCytotoxic Reactive Metabolite Assay with permeabilized cryopreserved human hepatocytes (MetMax™ Human Hepatocytes) for the evaluation of drug-induced liver injury (DILI) potential of drug candidates in drug development.
Hold your spot here >

Details

Start:
September 11, 2022
End:
September 15, 2022
Quick Links

Technologies

Development and Clinical
Trial Solutions

Privacy Settings